Nasal deformity. Q10-Q18 Congenital malformations of eye, ear, face and neck
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The inclusion criteria are presence of dorsal hump in a patient, who is candidate for primary rhinoplasty; ASA (American Society of Anesthesiologists) class I patients. The exclusion criteria are history of bleeding in patient or his or her family; consumption of drugs which intervene with coagulation system; consumption of oral contraceptive drugs; secondary nasal deformity.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symmetry of nasal dorsum. Timepoint: Ten days, 4 weeks, 3 monthes after intervention. Method of measurement: Questionnaire.;Compatibility rate of the amount of acquired hump reduction after surgery with the predetermined amount (during presurgical phase). Timepoint: Three monthes after iontervention. Method of measurement: Questionnaire.;Rate of patient’s satisfaction about final appearance of nasal dorsum. Timepoint: Three monthes after intervention. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bony irregularities of nasal dorsum. Timepoint: Ten days, 4 weeks, 3 monthes after intervention. Method of measurement: Questionnaire.;Bony prominence of nasal dorsum. Timepoint: Ten days, 4 weeks, 3 monthes after intervention. Method of measurement: Questionnaire.;Cutaneous complications in nasal dorsum. Timepoint: Ten days, 4 weeks, 3 monthes after intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Hamadan University of Medical Sciences